Chronic β-adrenergic activation-induced left ventricular systolic dysfunction is associated with systemic release of TNF-α and IL-1-β in rats

被引:0
作者
Santosh Kumar
Sandeep Seth
Amardeep Jaiswal
Rajesh Enjamoori
Amit K. Dinda
Ruma Ray
Subir K. Maulik
机构
[1] All India Institute of Medica Sciences,Department of Pharmacology
[2] All India Institute of Medica Sciences,Department of Cardiology
[3] All India Institute of Medica Sciences,Department of Pathology
来源
Pharmacological Reports | 2009年 / 61卷
关键词
echocardiography; myocardial function; cytokines;
D O I
暂无
中图分类号
学科分类号
摘要
The relationship between systemic cytokine release and chronic β-adrenergic activation-induced left ventricular dysfunction (LVSD) has not been widely reported in the literature. In the present study, we examined changes in the serum levels of inflammatory cytokines (IL-1-β, IL-6 and TNF-α) following chronic β-adrenergic activation-induced LVSD. Male Wistar rats were administered isoproterenol (ISO, 5 mg/kg, sc, once daily) for 4 weeks (ISO 4) or 12 weeks (ISO 12). Echocardiography was done and serum levels of IL-1-β, IL-6 and TNF-a were estimated at the end of each protocol. In the ISO 4 group, there was a significant increase in relative wall thickness (p < 0.01) and heart weight: body weight ratio (p < 0.001) without any significant changes in fractional shortening (FS) or serum cytokine levels. However, in the ISO 12 group, there was a 32% decrease in FS along with increased serum levels of IL-1-β and TNF-α. The present findings indicate that LVSD induced by chronic β-adrenergic activation in rats is accompanied by increased serum cytokine levels.
引用
收藏
页码:870 / 876
页数:6
相关论文
共 170 条
[1]  
Badenhorst D(2003)β-Adre-nergic activation initiates chamber dilatation in concentric hypertrophy Hypertension 41 499-504
[2]  
Veliotes D(1999)Myocardial tumor necrosis factor-α secretion in hypertensive and heart failure-prone rats Am J Physiol 277 H543-H550
[3]  
Maseko M(2009)Molecular determinants of heart failure with normal left ventricular ejection fraction Pharmacol Rep 61 139-145
[4]  
Tsotetsi OJ(2004)Potassium canrenoate, an aldosterone receptor antagonist, reduces isoprenaline-induced cardiac fibrosis in the rat J Pharmacol Exp Ther 309 1160-1166
[5]  
Brooksbank R(1998)Pathophysiologically relevant concentrations of tumor necrosis factor-a promote progressive left ventricular dysfunction and remodeling in rats Circulation 97 1382-1391
[6]  
Naidoo A W A(1999)Tumor necrosis factor-alpha and interleukin-1beta synergistically depress human myocardial function Crit Care Med 27 1309-1318
[7]  
Bergman MR(1998)Rat models of hypertension, cardiac hypertrophy and failure Cardiovasc Res 39 89-105
[8]  
Kao RH(2003)Regression of isoproterenol-induced cardiac hypertrophy by Na Hypertension 41 1324-1329
[9]  
McCune SA(2001)/H Pharmacol Res 44 311-315
[10]  
Holycross BJ(2004) exchanger inhibition Am J Physiol Heart Circ Physiol 287 H2762-H2767